Enter assignee name

Trademarks = 2

Forward Citations = 5

Loading Chart...

5 inventors (with patents filed for the assignee):

Jonathan Wall (5 out of 68 patents)

James S Foster (4 out of 8 patents)

Spencer Guthrie (4 out of 4 patents)

4. Jaume Pons (2 out of 4 patents)

5. Michael L Klein (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12264195 - Modified immunoglobulins for targeting amyloid deposits (2025-04-01),

2. 12161692 - SAP FC fusion proteins and methods of use (2024-12-10),

3. 12157765 - Modified immunoglobulins for targeting amyloid deposits (2024-12-03),

4. 12139529 - Antibody-peptide fusion proteins for treating amyloid disorders (2024-11-12),

5. 12030934 - Modified immunoglobulins for targeting amyloid deposits (2024-07-09),

Attralus, Inc. is a biotechnology company focused on developing innovative therapies for patients with rare diseases. The company leverages its proprietary technology platform to discover and develop novel treatments that address unmet medical needs. Attralus is committed to advancing science and improving patient outcomes through rigorous research and collaboration with healthcare professionals. With a strong emphasis on clinical development, Attralus aims to bring transformative therapies to market, enhancing the quality of life for individuals affected by challenging health conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

5 Patents

#44 in Burlingame, CA

#11,727 in California

#50,178 in US

Burlingame, CA, United States of America

Attralus, Inc.